Skip to NavigationSkip to content

News

An error in the automated system left 450,000 women without an invite for breast screening and Jeremy Hunt, the UK’s Health Secretary, said that 270...
Bristol-Myers Squibb has terminated two pivotal Phase 3 trials of BMS-986205, an IDO1 inhibitor, investigating its efficacy in non-small cell...
Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of accounting rules by the...
Aaron Traywick, who made headlines when he injected himself with an untested DIY herpes vaccine during a live streaming session on Facebook back in...
Novartis has announced that its CAR T treatment, Kymriah, has successfully been given a second indication for the treatment of relapsed or refractory...
Sanofi and Regeneron have decided to attempt to boost sales of Praluent by agreeing a deal that will see them reduce the price of the medicine to...
Porton Biopharma Limited (PBL) has officially opened the doors of its new fermentation facility, the principle function of which will be to produce...
Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type of cancer are set to greatly increase...
United Therapeutics is set to acquire speciality pharma firm SteadyMed after it emerged that the pair had signed a definitive merger agreement...
Building on the back of strong data released at the end of last year, Novartis has released further positive Phase 3 data on its treatment for...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches